Speakers

Esteemed Co-Chairs

Mary-Alice Barrett

Associate General Counsel
Genentech (Little Falls, NJ)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 • 8:45 am

Donald LeGower

Assistant General Counsel - Litigation and Government Investigations
Bristol-Myers Squibb (Lawrenceville, NJ)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 • 8:45 am

Lora Spencer

Principal Litigation & Investigations Counsel
Medtronic (Minneapolis, MN)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 • 8:45 am

Renowned Jurists

Honorable Rex Burlison

Circuit Judge
22nd Judicial Circuit of MO

And Now a Word from Our Judges: Judicial Perspectives on Managing Life Sciences Mass Tort Proceedings

December 7, 2022 • 10:30 am

Honorable Karen K. Caldwell

Chief Judge
U.S. District Court, E.D. Kentucky
Chair
Judicial Panel on Multidistrict Litigation (JPML) (Lexington, KY)

And Now a Word from Our Judges: Judicial Perspectives on Managing Life Sciences Mass Tort Proceedings

December 7, 2022 • 10:30 am

Hon. Brian H. May

Circuit Judge, Division 1
St. Louis County Circuit Court

And Now a Word from Our Judges: Judicial Perspectives on Managing Life Sciences Mass Tort Proceedings

December 7, 2022 • 10:30 am

Judge Robin Rosenberg

District Judge
U.S. District Court, S.D. of Florida
Chair, Civil Rules Advisory Committee
Chair, MDL Rules Subcommittee

Examining New Proposed MDL Rule Changes and What They Will Mean for Practitioners

December 6, 2022 • 9:45 am

Honorable Nancy J. Rosenstengel

Chief Judge
U.S. District Court, S.D. Illinois (East St. Louis, IL)

And Now a Word from Our Judges: Judicial Perspectives on Managing Life Sciences Mass Tort Proceedings

December 7, 2022 • 10:30 am

In-House Counsel

Mary-Alice Barrett

Associate General Counsel
Genentech (Little Falls, NJ)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 • 8:45 am

Adam Bassing

Head of Global Litigation
UCB, Inc.

Candace Camarata

Associate General Counsel
Becton, Dickinson and Company (New York, NY)

Coffee and Q+A with Our In-House Counsel on “What’s Keeping You Up at Night”: The Top 5 Things to Watch in the Current Products Liability Defense Environment

December 6, 2022 • 8:30 am

Bill Childs

Assistant General Counsel, Litigation
3M (St. Paul, Minnesota)

Workshop A — Focus Group on MDL Defense Strategies: Developing a Tactical Tool-Kit for Managing Unique MDL Challenges and Combatting Meritless Claims

December 5, 2022 • 9:00 am

Greg A. Dadika

Vice-President, Litigation, Governmental Investigations, and Risk Management
Boehringer Ingelheim (Ridgefield, CT)

Coffee and Q+A with Our In-House Counsel on “What’s Keeping You Up at Night”: The Top 5 Things to Watch in the Current Products Liability Defense Environment

December 6, 2022 • 8:30 am

Sandra Di lorio

Senior Litigation Counsel
Endo

A — Tactics for Combatting “Non-Traditional” Liability Theories in Drug and Medical Device Product Liability Cases

B — Addressing The Latest and Greatest in Plaintiffs’ Bar Attacks on OTC Drugs and Consumer Health Products

December 6, 2022 • 4:30 pm

Sarah Heineman

Senior Assistant General Counsel, Global Litigation
Bayer (Piitsburgh, PA)

Examining the Impact of Social Media and Voluntary Reporting on Today’s Drug and Device Product Liability Litigation Landscape

December 7, 2022 • 11:30 am

Christiana Jacxsens

Corporate Vice President, Deputy General Counsel, Head of Investigations and Litigation
B. Braun Medical (Atlanta, GA)

Coffee and Q+A with Our In-House Counsel on “What’s Keeping You Up at Night”: The Top 5 Things to Watch in the Current Products Liability Defense Environment

December 6, 2022 • 8:30 am

Marcela Kirberger

Executive Vice President, General Counsel & Corporate Secretary
Elanco

Amy Todd Klug

Associate General Counsel, Litigation & Corporate Operations, Legal Affairs
Daiichi Sankyo, Inc. (Basking Ridge, NJ)

Maximizing the Chances of Success in a “Bet-the-Company” Product Liability Litigation

December 6, 2022 • 3:15 pm

Donald LeGower

Assistant General Counsel - Litigation and Government Investigations
Bristol-Myers Squibb (Lawrenceville, NJ)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 • 8:45 am

Sarah Padgitt

Associate General Counsel
Baxter (Chicago, IL)

What Would You Do If?… Seasoned Drug and Medical Device Product Liability Litigators Share Lessons on Avoiding Ethical Compliance Traps

December 7, 2022 • 3:00 pm

Zane Riester

Senior Counsel
Johnson & Johnson (New Brunswick, NJ)

A — Too Big to Close: Effective Strategies for Wrapping Up an Unyielding MDL and Navigating the Remand Process

B — Insights from Frontline Litigators on Current Juror Perceptions and Behaviors: Thoughts on the Post-Pandemic Juror Mindset

December 6, 2022 • 5:30 pm

Lora Spencer

Principal Litigation & Investigations Counsel
Medtronic (Minneapolis, MN)

Co-Chairs’ Welcome Back and Recap of Day 1

December 7, 2022 • 8:45 am

Brennan Torregrossa

Senior Vice President, Head of Global Litigation
GSK (Philadelphia, PA)

Coffee and Q+A with Our In-House Counsel on “What’s Keeping You Up at Night”: The Top 5 Things to Watch in the Current Products Liability Defense Environment

December 6, 2022 • 8:30 am

Justin Witzmann

Senior Litigation Counsel
Nuvasive (San Diego, CA)

Examining Risks and Liabilities Associated with New Cutting Edge MedTech and HealthTech

December 7, 2022 • 1:00 pm

Law Firm Attorneys

Eric Alexander

Partner
Reed Smith LLP

Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

December 6, 2022 • 12:30 pm

Alana Bassin

Partner
Nelson Mullins Riley & Scarborough

A — Too Big to Close: Effective Strategies for Wrapping Up an Unyielding MDL and Navigating the Remand Process

B — Insights from Frontline Litigators on Current Juror Perceptions and Behaviors: Thoughts on the Post-Pandemic Juror Mindset

December 6, 2022 • 5:30 pm

Andrew T. (Andy) Bayman

Partner
King & Spalding LLP (Atlanta, GA)

And Now a Word from Our Judges: Judicial Perspectives on Managing Life Sciences Mass Tort Proceedings

December 7, 2022 • 10:30 am

Michelle M. Bufano

Partner
Patterson Belknap Webb & Tyler LLP (New York, NY)

Understanding How New Rule 702 Amendments Will Impact the Future Admissibility of Expert Testimony

December 6, 2022 • 11:30 am

Christopher G. Campbell

Partner
Chair, Product Liability and Mass Torts Practice
DLA Piper (Atlanta, GA)

Examining the Impact of Social Media and Voluntary Reporting on Today’s Drug and Device Product Liability Litigation Landscape

December 7, 2022 • 11:30 am

Christopher Carton

Managing Partner
Bowman & Brooke LLP (New Brunswick, NJ)

Lessons Learned from this Year’s Top MDLs: Key Defense Strategies from 3M Ear Plugs, Opioids and Zantac MDLs

December 7, 2022 • 9:00 am

Paul J. (PJ) Cosgrove

Partner | Co-Group Leader, Product Liability
Ulmer & Berne LLP (Cincinnati, OH)

A — Tactics for Combatting “Non-Traditional” Liability Theories in Drug and Medical Device Product Liability Cases

B — Addressing The Latest and Greatest in Plaintiffs’ Bar Attacks on OTC Drugs and Consumer Health Products

December 6, 2022 • 4:30 pm

Timothy Daniels

Partner
Irwin Fritchie Urquhart & Moore LLC (New Orleans, LA)

Understanding How New Rule 702 Amendments Will Impact the Future Admissibility of Expert Testimony

December 6, 2022 • 11:30 am

Sharon Desh

Partner
Winston & Strawn LLP (Chicago, IL)

Lessons Learned from this Year’s Top MDLs: Key Defense Strategies from 3M Ear Plugs, Opioids and Zantac MDLs

December 7, 2022 • 9:00 am

Jan Dodd

Shareholder
Carlton Fields (Los Angeles, CA)

Marcella Ducca

Co-Chair, Atlanta Products Liability Litigation Group
Greenberg Traurig LLP (Atlanta, GA)

Coffee and Q+A with Our In-House Counsel on “What’s Keeping You Up at Night”: The Top 5 Things to Watch in the Current Products Liability Defense Environment

December 6, 2022 • 8:30 am

Sean P. Fahey

Partner | Leader, Health Sciences Litigation Practice Group
Troutman Pepper (Philadelphia, PA)

Overcoming the Trials and Tribulations of Plaintiff Census Forms and Registries: What’s Working, What’s Not, and How Proposed MDL Rule Changes May Improve the System

December 6, 2022 • 10:45 am

Wendy West Feinstein

Wendy West Feinstein

Partner
Morgan, Lewis & Bockius LLP (Pittsburgh, PA)

A — Tactics for Combatting “Non-Traditional” Liability Theories in Drug and Medical Device Product Liability Cases

B — Addressing The Latest and Greatest in Plaintiffs’ Bar Attacks on OTC Drugs and Consumer Health Products

December 6, 2022 • 4:30 pm

David Ferrera

Partner
Nutter McClennen & Fish LLP (Boston, MA)

Drug and Medical Device Litigator Think-Tank: “What I Wish Was Done Differently During the Regulatory Approval Process”

December 6, 2022 • 2:30 pm

Kristen Fournier

Partner
King & Spalding LLP (New York, NY)

Workshop A — Focus Group on MDL Defense Strategies: Developing a Tactical Tool-Kit for Managing Unique MDL Challenges and Combatting Meritless Claims

December 5, 2022 • 9:00 am

Sabrina Gallo

Partner
Greenberg Traurig LLP, (Miami, FL)

Lessons Learned from this Year’s Top MDLs: Key Defense Strategies from 3M Ear Plugs, Opioids and Zantac MDLs

December 7, 2022 • 9:00 am

John Galvin

Partner
Thompson Coburn LLP (St. Louis, MO)

A — Too Big to Close: Effective Strategies for Wrapping Up an Unyielding MDL and Navigating the Remand Process

B — Insights from Frontline Litigators on Current Juror Perceptions and Behaviors: Thoughts on the Post-Pandemic Juror Mindset

December 6, 2022 • 5:30 pm

Ruben Gonzalez

Attorney
Faegre Drinker Biddle & Reath LLP (Chicago, IL)

Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

December 6, 2022 • 12:30 pm

Jessica Grant

Partner
Morrison Foerster LLP

Examining Risks and Liabilities Associated with New Cutting Edge MedTech and HealthTech

December 7, 2022 • 1:00 pm

Jacqueline Harrington

Partner
Dechert LLP (New York, NY)

When Products Liability and Enforcement Converge: Building a Holistic Defense Strategy for Tackling a Multi-Pronged Litigation

December 7, 2022 • 2:00 pm

Tripp Haston

Partner
Bradley (Birmingham, AL)

Drug and Medical Device Litigator Think-Tank: “What I Wish Was Done Differently During the Regulatory Approval Process”

December 6, 2022 • 2:30 pm

Michael Hecht

Partner
Venable (Baltimore, MD)

Understanding How New Rule 702 Amendments Will Impact the Future Admissibility of Expert Testimony

December 6, 2022 • 11:30 am

Tim Hudson

Partner
Barnes & Thornburg LLP (Dallas, TX)

Examining Risks and Liabilities Associated with New Cutting Edge MedTech and HealthTech

December 7, 2022 • 1:00 pm

Nilda Isidro

Shareholder
Greenberg Traurig LLP (New York, NY)

Christine Kain

Partner
Faegre Drinker Biddle & Reath LLP (Minneapolis, MN)

Overcoming the Trials and Tribulations of Plaintiff Census Forms and Registries: What’s Working, What’s Not, and How Proposed MDL Rule Changes May Improve the System

December 6, 2022 • 10:45 am

Andrew Kaplan

Partner
Crowell & Moring (Washington, DC)

When Products Liability and Enforcement Converge: Building a Holistic Defense Strategy for Tackling a Multi-Pronged Litigation

December 7, 2022 • 2:00 pm

Matthew Kelly

Shareholder
Segal McCambridge Singer & Mahoney (Chicago, IL)

Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

December 6, 2022 • 12:30 pm

Thomas Kurland

Counsel
Patterson Belknap Webb and Tyler LLP (New York, NY)

A — Tactics for Combatting “Non-Traditional” Liability Theories in Drug and Medical Device Product Liability Cases

B — Addressing The Latest and Greatest in Plaintiffs’ Bar Attacks on OTC Drugs and Consumer Health Products

December 6, 2022 • 4:30 pm

Paul LaFata

Partner
Dechert LLP

Examining New Proposed MDL Rule Changes and What They Will Mean for Practitioners

December 6, 2022 • 9:45 am

John P. Lavelle Jr.

John P. Lavelle, Jr.

Partner
Morgan Lewis & Bockius LLP (Philadelphia, PA)

Overcoming the Trials and Tribulations of Plaintiff Census Forms and Registries: What’s Working, What’s Not, and How Proposed MDL Rule Changes May Improve the System

December 6, 2022 • 10:45 am

Robin Linley

Partner
Blake, Cassels & Graydon LLP (Toronto, ON)

Examining Risks and Liabilities Associated with New Cutting Edge MedTech and HealthTech

December 7, 2022 • 1:00 pm

Robyn Maguire

Partner
Barnes & Thornburg LLP

What Would You Do If?… Seasoned Drug and Medical Device Product Liability Litigators Share Lessons on Avoiding Ethical Compliance Traps

December 7, 2022 • 3:00 pm

Kimberly Martin

Partner
Bradley (Huntsville, AL)

A — Too Big to Close: Effective Strategies for Wrapping Up an Unyielding MDL and Navigating the Remand Process

B — Insights from Frontline Litigators on Current Juror Perceptions and Behaviors: Thoughts on the Post-Pandemic Juror Mindset

December 6, 2022 • 5:30 pm

Stephen J. McConnell

Partner
Reed Smith LLP

A — Tactics for Combatting “Non-Traditional” Liability Theories in Drug and Medical Device Product Liability Cases

B — Addressing The Latest and Greatest in Plaintiffs’ Bar Attacks on OTC Drugs and Consumer Health Products

December 6, 2022 • 4:30 pm

Susanna Moldoveanu

Attorney
Butler Snow LLP (Memphis, TN)

Drug and Medical Device Litigator Think-Tank: “What I Wish Was Done Differently During the Regulatory Approval Process”

December 6, 2022 • 2:30 pm

Julie Park

Partner
Morrison Foerster LLP (San Diego, CA)

Maximizing the Chances of Success in a “Bet-the-Company” Product Liability Litigation

December 6, 2022 • 3:15 pm

Megan Rodgers

Partner
Covington & Burling LLP (Palo Alto, CA)

Workshop B — Diversity Equity & Inclusion Solution Room for the Life Sciences Products Liability Defense Bar: How Life Sciences Companies and Their Law Firm Partners Can Collaborate to Implement Successful DEI Initiatives

December 5, 2022 • 1:30 pm

Courtney Saleski

Partner
DLA Piper

When Products Liability and Enforcement Converge: Building a Holistic Defense Strategy for Tackling a Multi-Pronged Litigation

December 7, 2022 • 2:00 pm

Robert Simpson

Managing Partner
Shook Hardy & Bacon LLP (Hartford, CT)

A — Too Big to Close: Effective Strategies for Wrapping Up an Unyielding MDL and Navigating the Remand Process

B — Insights from Frontline Litigators on Current Juror Perceptions and Behaviors: Thoughts on the Post-Pandemic Juror Mindset

December 6, 2022 • 5:30 pm

David N. Sneed

Partner
Covington & Burling LLP (Washington, DC)

Understanding How New Rule 702 Amendments Will Impact the Future Admissibility of Expert Testimony

December 6, 2022 • 11:30 am

Jennifer Stevenson

Partner
Shook Hardy & Bacon LLP (Kansas City, MO)

Workshop A — Focus Group on MDL Defense Strategies: Developing a Tactical Tool-Kit for Managing Unique MDL Challenges and Combatting Meritless Claims

December 5, 2022 • 9:00 am

Charlotte Taylor

Partner
Jones Day

Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

December 6, 2022 • 12:30 pm

Amy Vanni

Partner
McCarter & English LLP (Philadelphia, PA)

A — Tactics for Combatting “Non-Traditional” Liability Theories in Drug and Medical Device Product Liability Cases

B — Addressing The Latest and Greatest in Plaintiffs’ Bar Attacks on OTC Drugs and Consumer Health Products

December 6, 2022 • 4:30 pm

Davis Walsh

Partner
McGuireWoods LLP (Richmond, VA)

Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

December 6, 2022 • 12:30 pm

Grant Worden

Partner
Torys LLP (Toronto, ON)

Maximizing the Chances of Success in a “Bet-the-Company” Product Liability Litigation

December 6, 2022 • 3:15 pm

Mary Young

Partner
Norton Rose Fulbright US LLP (Minneapolis, MN)

Maximizing the Chances of Success in a “Bet-the-Company” Product Liability Litigation

December 6, 2022 • 3:15 pm

Consultancies

Megan Pizor

General Counsel
Litigation Management, Inc. (Mayfield Heights, OH)

Overcoming the Trials and Tribulations of Plaintiff Census Forms and Registries: What’s Working, What’s Not, and How Proposed MDL Rule Changes May Improve the System

December 6, 2022 • 10:45 am

Christina Marinakis

Jury Consulting & Strategy Advisor
IMS Consulting & Expert Services, LLC

Maximizing the Chances of Success in a “Bet-the-Company” Product Liability Litigation

December 6, 2022 • 3:15 pm